-
Regulated GDNF Gene Therapy: A Novel Regulatory System Based on Protein Degradation
… grant: Regulated GDNF Gene Therapy: a Novel Regulatory System Based on Protein Degradation Promising Outcomes of … step towards development of a new regulatable gene therapy system for trophic factors to combat Parkinson’s disease. …
-
Research Paper Adds Clinical Anchors to Proposed Parkinson’s Staging System
October 11, 2024
… the Neuronal alpha-Synuclein Disease Integrated Staging System (NSD-ISS) . The FDA acknowledged the potential of … fine-tune these definitions and improve the staging system even further. The NSD-ISS framework, bolstered by …
-
The Four Horsemen of G2019S
… G2019S variant of LRRK2 are abnormally sensitive to immune system molecules that naturally increase in the body with … … Inflammation … California … LRRK2 … LRRK2 in the Immune System … Theo D. Palmer, PhD …
-
Development of a Cellular System to Screen for Small Molecules that Upregulate the hVMAT2 Promoter Activity
… Objective/Rationale: We will develop an essential cellular system as a platform for future high throughput screen (HTS) … development. Project Description: To establish the cellular system, we will genetically engineer SH-SY5Y cells to link …
-
The Michael J. Fox Foundation to Fund $2 Million for Study of Midbrain System
October 22, 2003
… suggests that greater insight into the entire dopaminergic system, including its development, will increase … Patterning, and Maintenance of Midbrain Dopaminergic Systems In the Normal and Parkinsonian Brain is one element …
-